TLR3 and cancer: Moreover, numerous cancers are characterized by upregulation of TLR3, a receptor for poly(I:C), and in most of these cancers this TLR3 positivity is predictive of a favorable outcome if poly(I:C) is used as an immune therapeutic13–18.